Is It Time to Buy the Dow Jones Industrial Average's Three Worst-Performing January Stocks?
These blue chips aren't quite the Dow's Dogs, but they're limping into February. After outperforming the other two major indices in 2022, the Dow Jones Industrial Average (DJI 0.78%) trailed the pack in January.
Though the Dow gained in January, it only gained 2.8% in February because it does not have as much exposure to technology stocks as the S&P 500 or the Nasdaq.
Using the Dogs of the Dow strategy as a guide, let's see if any of the Dow's worst performers in January are worth buying today.
Johnson & Johnson (down 7.5%)
1
Johnson & Johnson (JNJ 0.02%) is a rock-solid blue chip stock, but the healthcare behemoth faced several negative headlines in January, sending its stock down, and its earnings report failed to impress the market.
Procter & Gamble (down 6.1%)
2
Procter & Gamble (PG -0.98%), another classic blue chip stock, manufactures household staples such as Gillette razors, Tide detergent, and Pampers diapers.
UnitedHealth (down 5.8%)
3
Finally, another leading healthcare stock, UnitedHealth (UNH 0.34%), rounds out the list, finishing the month down 5.8%.
13+ Best Undervalued Stocks As Per 2023 (Watchlist)